(Q36960502)

17 August 2017

1 reference

title

Adjuvants in vaccines and for immunisation: current trends (English)

1 reference

17 August 2017

Pieranna Chiarella

1

1 reference

17 August 2017

Emanuela Massi

2

1 reference

17 August 2017

Mariangela De Robertis

3

1 reference

17 August 2017

Emanuela Signori

4

1 reference

17 August 2017

Vito Michele Fazio

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1551-1562

1 reference

Approaching the asymptote? Evolution and revolution in immunology

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Stability and functional effectiveness of phosphorothioate modified duplex DNA and synthetic 'mini-genes'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Biological features of genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Particulate delivery systems for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Survey of human-use adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase -- increased expression with reduced muscle damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Inflammatory responses following direct injection of plasmid DNA into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Structure of the receptor binding fragment HC of tetanus neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Enhancement of antibody responses in DNA vaccination using a vector encoding a universal T-helper cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

A plasmid family containing two different expression cassettes suitable for immunomodulation and genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Mechanisms for induction of acquired host immunity by neutrophil peptide defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Adjuvant activity of interferon alpha: mechanism(s) of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Lipopolysaccharide: Structure, Bioactivity, Receptors, and Signal Transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Identification of two promiscuous T cell epitopes from tetanus toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

Antigenicity of Soluble Protein in the Presence of High Levels of Antibody : a Possible Mode of Action of the Antigen Adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1551

10.1517/14712598.7.10.1551

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference